Literature DB >> 9549522

The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates.

P Giunti1, G Sabbadini, M G Sweeney, M B Davis, L Veneziano, E Mantuano, A Federico, R Plasmati, M Frontali, N W Wood.   

Abstract

The spinocerebellar ataxia type 2 (SCA2) is caused by a trinucleotide (CAG) expansion in the coding region of the ataxin 2 gene on chromosome 12q.89 families with autosomal dominant cerebellar ataxia (ADCA) types I, II and III, and 47 isolated cases with idiopathic late onset cerebellar ataxia (ILOCA), were analysed for this mutation. The identification of the SCA2 mutation in 31 out of 38 families with the ADCA I phenotype, but in none of those with ADCA II, ADCA III or ILOCA confirms the specificity of this mutation. A clinical comparison of the ADCA I patients with the three known mutations (SCA1, -2 or -3) highlights significant differences between the groups; SCA2 patients tended to have a longer disease duration, a higher frequency of slow saccades and depressed tendon reflexes. However, these neurological signs were also seen in an ADCA I family in which the SCA2 mutation was not identified, illustrating the importance of a direct genetic test. The SCA2 families were from different geographical and ethnic backgrounds. However, haplotype analysis failed to show evidence of a founder mutation, even in families from the same geographical origin. The range of normal alleles varied from 17 to 30 CAG repeats and from 35 to 51 repeats for the pathological alleles. Similar to the other diseases caused by unstable trinucleotide repeats, a significant inverse correlation has been found between the number of repeats and age of onset, and there is a significantly higher paternal instability of repeat length on transmission to offspring. The SCA2 mutation is the most frequent amongst ADCA I patients, accounting for 40%, compared with SCA1 and SCA3 which account for 35% and 15%, respectively.

Entities:  

Mesh:

Year:  1998        PMID: 9549522     DOI: 10.1093/brain/121.3.459

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

Review 1.  The complex clinical and genetic classification of inherited ataxias. I. Dominant ataxias.

Authors:  S Di Donato
Journal:  Ital J Neurol Sci       Date:  1998-12

2.  Cervical dystonia in spinocerebellar ataxia type 2: clinical and polymyographic findings.

Authors:  S M Boesch; J Müller; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

3.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

4.  Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation.

Authors:  P Giunti; G Stevanin; P F Worth; G David; A Brice; N W Wood
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

Review 5.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

Review 6.  A comprehensive review of spinocerebellar ataxia type 2 in Cuba.

Authors:  Luis Velázquez-Pérez; Roberto Rodríguez-Labrada; Julio Cesar García-Rodríguez; Luis Enrique Almaguer-Mederos; Tania Cruz-Mariño; José Miguel Laffita-Mesa
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

7.  Autosomal dominant cerebellar ataxia: SCA2 is the most frequent mutation in eastern India.

Authors:  K K Sinha; P F Worth; D K Jha; S Sinha; V J Stinton; M B Davis; N W Wood; M G Sweeney; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

8.  The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study.

Authors:  Mark Wardle; Elisa Majounie; Mustapha B Muzaimi; Nigel M Williams; Huw R Morris; Neil P Robertson
Journal:  J Neurol       Date:  2009-03-06       Impact factor: 4.849

9.  Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases.

Authors:  Keizo Sugaya; Shiro Matsubara
Journal:  Mol Neurodegener       Date:  2009-07-15       Impact factor: 14.195

10.  ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice.

Authors:  Ewa Damrath; Melanie V Heck; Suzana Gispert; Mekhman Azizov; Joachim Nowock; Carola Seifried; Udo Rüb; Michael Walter; Georg Auburger
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.